Abstracts Archive - Page 1629 of 2425 - ACR Meeting Abstracts

Abstract Number: 3181 • 2016 ACR/ARHP Annual Meeting
The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis
Rennie L. Rhee¹, John C. Davis², Linna Ding³, Fernando Fervenza⁴, Gary S. Hoffman⁵, Cees G.M. Kallenberg⁶, Carol A. Langford⁷, W Joseph McCune⁸, Paul A. Monach⁹, Philip Seo¹⁰, Robert F. Spiera¹¹, Eugene William St.Clair¹², Ulrich Specks⁴, John H. Stone¹³ and Peter A. Merkel¹⁴, ¹Rheumatology, University of Pennsylvania, Philadelphia, PA, ²Baxalta, Cambridge, MA, ³NIH, Bethesda, MD, ⁴Mayo Clinic, Rochester, MN, ⁵Rheumatology, Cleveland Clinic, Cleveland, OH, ⁶Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, ⁷Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, ⁸Int Med/ Rheum, University of Michigan, Ann Arbor, MI, ⁹Rheumatology, Boston University School of Medicine, Boston, MA, ¹⁰Medicine, Johns Hopkins University, Baltimore, MD, ¹¹Hospital for Special Surgery, Cornell, New York, NY, ¹²Rheumatology and Immunology, Duke University, Durham, NC, ¹³Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA, ¹⁴Division of Rheumatology, Univ of Pennsylvania; Perelman School of Med, Philadelphia, PA
Background/Purpose: The significance of persistent hematuria or proteinuria in patients with ANCA-associated vasculitis (AAV) who are in clinical remission is still unclear. This study…
Abstract Number: 3182 • 2016 ACR/ARHP Annual Meeting
Attenuation of Fluorine-18-Fluorodeoxyglucose Uptake in Large Vessel Giant Cell Arteritis after Short-Term High-Dose Steroid Treatment – a Diagnostic Window of Opportunity
Berit Dalsgaard Nielsen¹, Ib Tønder Hansen², Kresten Krarup Keller³, Philip Therkildsen⁴, Ellen-Margrethe Hauge³ and Lars Christian Gormsen⁵, ¹Rheumatology, Department of Rheumatology, Aarhus University Hospital, Århus C, Denmark, ²Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, ³Rheumatology, Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, ⁴Department of Rheumatology, Aarhus University Hospital, Aarhus C, Denmark, ⁵Nuclear Medicine and PET Center, Department of Nuclear Medicine and PET Center, Aarhus University Hospital, Århus C, Denmark
Background/Purpose: Fluorine-18-fluorodeoxyglucose (18F-FDG) PET/CT is, due to its excellent diagnostic accuracy[1], increasingly used to diagnose large vessel GCA (LV-GCA). However, PET/CT is not always readily…
Abstract Number: 3183 • 2016 ACR/ARHP Annual Meeting
Tocilizumab for the Treatment of Giant Cell Arteritis – MR-Angiography Results from the First Randomized Placebo-Controlled Trial
Stephan Reichenbach^1,2, Sabine Adler³, Jennifer Cullmann⁴, Harald Bonel⁴, Stefan Kuchen⁵, Felix Wermelinger¹, Diana Dan¹, Michael Seitz¹ and Peter M. Villiger¹, ¹Department of Rheumatology, Immunology and Allergology, University Hospital Bern, Bern, Switzerland, ²Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland, ³Rheumatology, Immunology, Allergology, University Hospital Bern, Bern, Switzerland, ⁴Department of Diagnostic, Interventional and Pediatric Radiology, University Hospital Bern, Bern, Switzerland, ⁵Rheumatology, Immunology, and Allergology, University of Bern, Bern, MD, Switzerland
Background/Purpose: As published in The Lancet online, March 4, 2016, the first randomized, placebo-controlled trial (RCT) of tocilizumab (TCZ) in giant cell arteritis (GCA) showed…
Abstract Number: 3184 • 2016 ACR/ARHP Annual Meeting
Antiphospoholipid Antibodies in Giant Cell Arteritis. What Can They Tell Us?
Alojzija Hocevar, Rok Jese, Ziga Rotar, Polona Žigon, Saša Čučnik and Matija Tomšič, Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia
Background/Purpose: The aim of our prospective study was to evaluate the potential impact of the antiphospholipid antibodies (aPL-Abs) on the clinical presentation of giant cell…
Abstract Number: 3185 • 2016 ACR/ARHP Annual Meeting
Sensitivity Analysis for the Smoking Paradox in the Development of Psoriatic Arthritis Among Psoriasis Patients
Uyen-Sa D.T. Nguyen^1,2, Yuqing Zhang², David T. Felson^2,3,4, Michael P. Lavalley⁵ and Hyon K. Choi⁶, ¹Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, ²Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, ³Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, ⁴Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, University of Manchester, Manchester, United Kingdom, ⁵Biostatistics, Boston University School of Public Health, Boston, MA, ⁶Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
Background/Purpose: Smoking is a strong risk factor for psoriasis and psoriatic arthritis, but several studies have found that smoking is inversely associated with the risk…
Abstract Number: 3186 • 2016 ACR/ARHP Annual Meeting
Determinants of Patient-Physician Discordance in Global Assessment in Psoriatic Arthritis and Levels of Discordance According to Disease Activity: A Multicenter European Study
Carole Desthieux¹, Benjamin Granger², Andra Rodica Balanescu³, P Balint⁴, Jürgen Braun⁵, Juan Canete⁶, Turid Heiberg⁷, Philip S. Helliwell⁸, Umut Kalyoncu⁹, Tore K Kvien¹⁰, Uta Kiltz⁵, Dora Niedermayer¹¹, Kati Otsa¹², Rossana Scrivo¹³, Josef Smolen¹⁴, Tanja A. Stamm¹⁵, Douglas J. Veale¹⁶, Kurt de Vlam¹⁷, Maarten de Wit¹⁸ and Laure Gossec¹, ¹Rheumatology, Pitié Salpêtrière Hospital, Paris, France, ²Biostatistics, Pitié Salpêtrière Hospital, Paris, France, ³Department of Internal Medicine and Rheumatology “Sf. Maria” Hospital, Bucharest, Romania, ⁴Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, ⁵Rheumazentrum Ruhrgebiet, Herne, Germany, ⁶Rheumatology, Hospital Clínic and IDIBAPS, Barcelona, Spain, ⁷Oslo University Hospital, Oslo, Norway, ⁸NIHR-Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, ⁹Hacettepe University, Ankara, Turkey, ¹⁰Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ¹¹PsAID taskforce, EULAR, Zurich, Switzerland, ¹²Rheumatology, Tallinn Central Hospital, Tallinn, EE, ¹³Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy, ¹⁴Medical University of Vienna and Hietzing Hospital, Vienna, Austria, ¹⁵Internal Medicine III, Vienna Medical University, Vienna, Austria, ¹⁶Consultant Rheumatologist, Centre for Arthritis and Rheumatic Disease, St. Vincent’s University Hospital and University College Dublin, Dublin 4, Ireland, ¹⁷Katholieke Universiteit Leuven, Leuven, Belgium, ¹⁸Medical Humanities, VU Medical Centre, Amsterdam, Netherlands
Background/Purpose: In the management of chronic diseases, recommendations insist on the need to work in partnership with the patient. Patient-physician discordance in global assessment of…
Abstract Number: 3187 • 2016 ACR/ARHP Annual Meeting
Societal Costs and Patients’ Experience of Health Inequities from Psoriatic Arthritis: A Danish Cohort Study
Lars Erik Kristensen¹, Tanja S Jørgensen², Robin Christensen³, Henrik Gudbergsen⁴, Lene Dreyer⁵, Christine Ballegaard⁶, Lennart T.H. Jacobsson⁷, Vibeke Strand⁸, Philip J Mease⁹ and Jakob Kjellberg¹⁰, ¹Musculoskeletal Statistics Unit, The Parker Institute, Dept. of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark, ²The Parker Institute, Copenhagen, Denmark, ³Musculoskeletal Statistics Unit, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark, ⁴Knowledge Centre for Telemedicine and Departments of Rheumatology, Copenhagen University Hospitals, Glostrup, Frederiksberg and Bispebjerg, Frederiksberg, Denmark, ⁵Internal Medicine - Rheumatology Section, Copenhagen University Hospital at Gentofte, Copenhagen, Denmark, ⁶The Parker institute, Copenhagen, Denmark, ⁷Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden, ⁸Stanford University School of Medicine, Palo Alto, CA, ⁹University of Leeds, Leeds, United Kingdom, ¹⁰Danish Institute for Local and Regional Government Research, Copenhagen, Denmark, Copenhagen, Denmark
Background/Purpose: Psoriatic arthritis (PsA), a chronic inflammatory joint disorder typically affecting individuals with psoriasis of the skin, is associated with severe comorbidities, reduced quality of…
Abstract Number: 3188 • 2016 ACR/ARHP Annual Meeting
Association of Gout with Risk of Advanced Chronic Kidney Disease
Austin Stack¹, Betina Blak², Michelle Johnson³, Victoria Parsons³, Andrew Maguire⁴, Alyssa B Klein⁵, John Ferguson⁶ and Robert Morlock⁷, ¹Nephrology, University Hospital Limerick & Health Research Institute,University of Limerick, Limerick, Ireland, ²AstraZeneca,, Luton, United Kingdom, ³Oxon Epidemiology Ltd, London, United Kingdom, ⁴Epidemiology, Oxon Epidemiology Ltd, London, United Kingdom, ⁵AstraZeneca, Gaithersburg, MD, ⁶Graduate Entry Medical School, University of Limerick, Limerick, Ireland, ⁷Ardea Biosciences, Inc., San Diego, CA
Background/Purpose: It is speculated that gout is a risk factor for kidney disease progression. The aim of this study was to evaluate the association of…
Abstract Number: 3189 • 2016 ACR/ARHP Annual Meeting
Patient Perceptions of Glucocorticoid Side Effects: A Survey of Users in an Online Health Community
Ruth Costello¹, Rikesh Patel¹, Jennifer Humphreys¹, John McBeth¹ and William G Dixon², ¹Manchester Academic Health Science Centre, Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom, ²Manchester Academic Health Sciences Centre, Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom
Background/Purpose: Glucocorticoids (GC) are widely used to treat inflammatory diseases, but are known to have many side effects. Patients’ perspectives of side effects are known…
Abstract Number: 3190 • 2016 ACR/ARHP Annual Meeting
Epidemiology of Polymyalgia Rheumatica 2000-2014: A Population Based Study
Shafay Raheel¹, Cynthia S. Crowson² and Eric L. Matteson¹, ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Health Sciences Research, Mayo Clinic, Rochester, MN
Background/Purpose: To determine time trends in the incidence and survival analysis of polymyalgia rheumatica (PMR) over a 15 year period in a geographically defined population…
Abstract Number: 3191 • 2016 ACR/ARHP Annual Meeting
Coronary Revascularization Procedure Rates and Risks Among Patients with Systemic Lupus Erythematosus Compared to Those with Diabetes Mellitus in a Nationwide Medicaid Cohort
Medha Barbhaiya¹, Candace H. Feldman¹, Sarah K. Chen², Hongshu Guan³, Tzu-Chieh Lin¹, Michael A. Fischer⁴, Daniel H. Solomon⁵, Brendan M. Everett⁶ and Karen H. Costenbader¹, ¹Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ²Beth Israel Deaconess Medical Center, Boston, MA, ³Rheumatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁴Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁵Division of Rheumatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁶Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
Background/Purpose : We have recently found that myocardial infarction (MI) risk was similar among age- and sex-matched SLE patients compared to diabetes mellitus (DM) patients…
Abstract Number: 3192 • 2016 ACR/ARHP Annual Meeting
Influence of Temperature and Humidity on Disease Activity in Rheumatoid Arthritis
Peter Mandl¹, Farideh Alasti¹, Rainer Kaltenberger², Thomas Krennert², Gabriela Supp¹, Uriel Landesmann¹, Josef S. Smolen³ and Daniel Aletaha⁴, ¹Department of Internal Medicine III; Division of Rheumatology, Medical University Vienna, Vienna, Austria, ²Central Institute for Meteorology and Geodynamics, Vienna, Austria, ³Department of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, ⁴Department of Internal Medicine 3, Medical University of Vienna, Vienna, Austria
Background/Purpose: To evaluate whether meteorological parameters influence pain and disease activity in patients with rheumatoid arthritis (RA). Methods: We assessed correlations between individual meteorological variables…
Abstract Number: 3193 • 2016 ACR/ARHP Annual Meeting
Is an Intensive Diet and Exercise Regimen Cost-Effective for Obese and Overweight Patients with Symptomatic Knee OA?
Elena Losina¹, Karen C. Smith², A. David Paltiel³, Lisa Gale Suter⁴, Jeffrey N. Katz⁵ and Stephen P. Messier⁶, ¹Orthopedics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ²Orthopaedics, Brigham and Women's Hospital, Boston, MA, ³Yale University, New Haven, CT, ⁴Medicine, Rheumatology, Yale University, New Haven, CT, ⁵Orthopaedics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁶Department of Health and Exerc, Wake Forest University, Winston-Salem, NC
Background/Purpose: About 50% of persons with knee OA are obese. Quality-adjusted life-year losses due to knee OA and obesity exceed 3.5 per person. The results…
Abstract Number: 3194 • 2016 ACR/ARHP Annual Meeting
Factors Related to Physicians’ Prescriptions for Rheumatoid Arthritis Drugs Never Filled or Subsequently Discontinued By Patients
Hong J. Kan¹, Kirill Dyagilev¹, Peter Schulam², Suchi Saria¹, Charles Molta³ and Jeffrey Curtis⁴, ¹John Hopkins University, Baltimore, MD, ²Department of Computer Science, Johns Hopkins University, Baltimore, MD, ³Sun Pharmaceutical, Cranbury, NJ, ⁴Division Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Rheumatologists have many choices of medications to use for patients with rheumatoid arthritis (RA), but patients may not fill a prescription (primary non-adherence or…
Abstract Number: 3195 • 2016 ACR/ARHP Annual Meeting
Patterns and Predictors of Hydroxychloroquine Nonadherence in a Nationwide Cohort of Medicaid Beneficiaries with Systemic Lupus Erythematosus
Candace H. Feldman¹, Jamie E. Collins², Zhi Zhang³, Daniel H. Solomon⁴, Karen H. Costenbader¹ and Ichiro Kawachi⁵, ¹Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ²Orthopaedic and Arthritis Center for Outcomes Research, Department of Orthopedic Surgery, Brigham & Women's Hospital, Boston, MA, ³Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁴Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, ⁵Social and Behavioral Sciences, Harvard T. H. Chan School of Public Health, Boston, MA
Background/Purpose: Hydroxychloroquine (HCQ) is the standard of care medication for most SLE patients, however cross-sectional studies suggest that nonadherence is common. Similar to the fluctuating…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].